Literature DB >> 9771666

An 8-year longitudinal study of muscle strength, muscle fiber size, and dynamic electromyogram in individuals with late polio.

G Grimby1, E Stålberg, A Sandberg, K S Sunnerhagen.   

Abstract

Twenty-one subjects with polio 24 to 51 years prior to the first examination were studied on three occasions, each 4 years apart with measurements of muscle strength and endurance for knee extension, macro EMG, and muscle biopsy from vastus lateralis. On average the muscle strength decreased during the 8-year follow-up by 9-15%. Endurance decreased during the observation period. The muscle fiber area was markedly increased in most subjects. There was a decrease in the capillarization during the follow-up. Macro EMG was increased in all subjects (range 3-42 times control) and increased in 20 legs during the 8-year follow-up, but showed a decrease in 8 of 9 legs with an approximative breakpoint when macro MUPs were around 20 times the normal size. Thus, evidence of on-going denervation/reinnervation as well as of failing capacity to maintain large motor units was demonstrated. SFEMG showed a moderate degree of disturbed neuromuscular transmission.

Mesh:

Substances:

Year:  1998        PMID: 9771666     DOI: 10.1002/(sici)1097-4598(199811)21:11<1428::aid-mus10>3.0.co;2-x

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  12 in total

1.  Perceived health in a population based sample of victims of the 1956 polio epidemic in the Netherlands.

Authors:  F Nollet; B Ivanyi; A Beelen; R J De Haan; G J Lankhorst; M De Visser
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-12       Impact factor: 10.154

2.  High-energy phosphate transfer in human muscle: diffusion of phosphocreatine.

Authors:  Refaat E Gabr; Abdel-Monem M El-Sharkawy; Michael Schär; Robert G Weiss; Paul A Bottomley
Journal:  Am J Physiol Cell Physiol       Date:  2011-03-02       Impact factor: 4.249

3.  Update on current and emerging treatment options for post-polio syndrome.

Authors:  Elisabeth Farbu
Journal:  Ther Clin Risk Manag       Date:  2010-07-21       Impact factor: 2.423

4.  Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.

Authors:  H L D Horemans; F Nollet; A Beelen; G Drost; D F Stegeman; M J Zwarts; J B J Bussmann; M de Visser; G J Lankhorst
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

5.  Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up.

Authors:  Henrik Gonzalez; Mohsen Khademi; Kristian Borg; Tomas Olsson
Journal:  J Neuroinflammation       Date:  2012-07-09       Impact factor: 8.322

Review 6.  Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis.

Authors:  Yao-Hsien Huang; Hung-Chou Chen; Kuang-Wei Huang; Po-Chih Chen; Chaur-Jong Hu; Chin-Piao Tsai; Ka-Wai Tam; Yi-Chun Kuan
Journal:  BMC Neurol       Date:  2015-03-22       Impact factor: 2.474

7.  Characteristics of Patients at First Visit to a Polio Clinic in Sweden.

Authors:  Katarina Skough Vreede; Katharina S Sunnerhagen
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

8.  Age at spinal cord injury determines muscle strength.

Authors:  Christine K Thomas; Robert M Grumbles
Journal:  Front Integr Neurosci       Date:  2014-01-23

9.  Normal serum levels of immune complexes in postpolio patients.

Authors:  Eva Melin; Azita Sohrabian; Johan Rönnelid; Kristian Borg
Journal:  Results Immunol       Date:  2014-06-18

10.  Reliability of contractile properties of the knee extensor muscles in individuals with post-polio syndrome.

Authors:  Eric L Voorn; Merel A Brehm; Anita Beelen; Arnold de Haan; Frans Nollet; Karin H L Gerrits
Journal:  PLoS One       Date:  2014-07-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.